• July 25, 2021
    • Loading stock data...
  • German Medical Cannabis Milestone As First Homegrown Flowers Distributed To Patients

    LinkedIn

    HOMEGROWN medical cannabis is now available to German patients for the first time.

    Aphria RX– a wholly-owned subsidiary of Canadian pharmaceutical and cannabis company Tilray – has become the first of the three licensed German producers to achieve this significant milestone.

    The medical cannabis crop is the first grown under European Good Manufacturing Practice (EU-GMP) standard in Tilray’s 6,000sq m indoor growing facility in Neumünster, about 40 miles from Hamburg.

    Aphria was one of three companies, along with Aurora and Demecan, to be granted a permit by the Federal Institute for Drugs and Medical Devices (BfArM), in spring 2019, to cultivate medicinal cannabis.

    Ground-Breaking Achievement

    Distribution of Aphria’s harvest to Germany’s pharmacies will be carried out by Frankfurt-based Cansativa. It won the the four-year contract year to become the sole distributor of all cannabis grown in Germany.

    The delivery has been hailed as a ground-breaking achievement by Tilray’s International Director and Chief Strategy Officer, Denise Faltischek, who said: “Our harvest in Germany represents an important milestone in providing access to high-quality, reliable medical cannabis to patients and healthcare professionals in Germany.”

    Read full article here: https://businesscann.com/german-medical-cannabis-milestone-as-first-homegrown-flowers-distributed-to-patients/?mc_cid=a8cd7cea30&mc_eid=e2114bb512

    Share.

    About Author

    Comments are closed.